ZANIDATAMAB-HRII

ZANIDATAMAB-HRII was reported 82 times

These side effects are most commonly reported by patients taking ZANIDATAMAB-HRII:

# Side effect Count
0 OFF LABEL USE 23
1 INFUSION RELATED REACTION 11
2 DIARRHOEA 10
3 CHILLS 9
4 PYREXIA 6
5 EJECTION FRACTION DECREASED 4
6 HYPERPYREXIA 3
7 ACUTE KIDNEY INJURY 2
8 ARTHRALGIA 2
9 DISEASE PROGRESSION 2
10 DRUG INEFFECTIVE 2
11 GASTROINTESTINAL HAEMORRHAGE 2
12 HYPERSENSITIVITY 2
13 OXYGEN SATURATION DECREASED 2
14 PLATELET COUNT DECREASED 2
15 PNEUMONITIS 2
16 RASH 2
17 ADRENAL INSUFFICIENCY 1
18 ARRHYTHMIA 1
19 BLOOD BILIRUBIN INCREASED 1
20 BLOOD PRESSURE INCREASED 1
21 CARDIAC ARREST 1
22 CARDIAC FAILURE 1
23 CHEST DISCOMFORT 1
24 COMA 1
25 COUGH 1
26 DEATH 1
27 DIZZINESS 1
28 DRUG EFFECT LESS THAN EXPECTED 1
29 DRY EYE 1
30 DYSPNOEA 1
31 ENCEPHALOPATHY 1
32 EYE INFLAMMATION 1
33 FACE OEDEMA 1
34 FALL 1
35 FEELING COLD 1
36 FEELING HOT 1
37 FREQUENT BOWEL MOVEMENTS 1
38 FULL BLOOD COUNT ABNORMAL 1
39 GASTROINTESTINAL SOUNDS ABNORMAL 1
40 HEADACHE 1
41 HEART RATE INCREASED 1
42 HEPATIC INFECTION 1
43 HER2 POSITIVE GASTRIC CANCER 1
44 HOSPITALISATION 1
45 HYPERTENSION 1
46 IMMUNE-MEDIATED ENTEROCOLITIS 1
47 INTENTIONAL DOSE OMISSION 1
48 JOINT STIFFNESS 1
49 LARYNGEAL OEDEMA 1
50 LEFT VENTRICULAR DYSFUNCTION 1
51 LIVER ABSCESS 1
52 MEDICATION ERROR 1
53 METASTASES TO CENTRAL NERVOUS SYSTEM 1
54 MITRAL VALVE INCOMPETENCE 1
55 NASOPHARYNGITIS 1
56 NAUSEA 1
57 NEUROPATHY PERIPHERAL 1
58 OCULAR DISCOMFORT 1
59 ONYCHOCLASIS 1
60 PAPULE 1
61 PRODUCT IMPURITY 1
62 PRODUCTIVE COUGH 1
63 PRURITUS 1
64 RECURRENT CANCER 1
65 RENAL IMPAIRMENT 1
66 RESPIRATORY FAILURE 1
67 RESPIRATORY RATE INCREASED 1
68 RETINAL HAEMORRHAGE 1
69 SEPSIS 1
70 SINUS TACHYCARDIA 1
71 SOMNOLENCE 1
72 STRESS CARDIOMYOPATHY 1
73 TACHYPNOEA 1
74 THERAPEUTIC PRODUCT EFFECT DECREASED 1
75 TRANSAMINASES INCREASED 1
76 VISION BLURRED 1
77 VOMITING 1
78 WEIGHT INCREASED 1
79 WHEEZING 1